In The News
Access to Compounds
Information about selected novel compounds discovered or used in the Conn Lab
Our goal is to make all published compounds developed in our labs available to the scientific community. While our limited capacity for synthesis prevents us from supplying our compounds on a broad basis, we are pleased that some compounds have been made available through commercial vendors. In addition, we provide detailed synthetic protocols for novel compounds to facilitate their synthesis by other laboratories. Below is a partial list of commercially available compounds and their sources followed by links to synthetic protocols of other compounds that we have reported. The following is provided for informational purposes only.
| mGluR1 Positive Allosteric Modulators | |
Ro 67-4853
|
![]() |
| mGluR4 Positive Allosteric Modulators | |
PHCCC
Abcam Biochemicals
|
![]() |
VU0155041
Abcam Biochemicals
|
![]() |
| VU0361737
|
![]() |
| mGluR5 Positive Allosteric Modulators | |
CDPPB 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide EMD Biosciences Cat. no. 445865 Tocris Bioscience Cat. no. 3235 Abcam Biochemicals Cat. no. Asc-363 |
![]() |
CPPHA N-[4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide Axon Medchem Cat. no. Axon 1431
|
![]() |
DCB 3,3'-Dichlorobenzaldazine or (1E,2E)-1,2-bis(3-chlorobenzylidene)hydrazine Santa Cruz Biotechnology Cat. no. sc-203560 Tocris Bioscience Cat. no. 1952 |
|
DFB 3,3'-Difluorobenzaldazine or (1E,2E)-1,2-bis(3-fluoroenzylidene)hydrazine Santa Cruz Biotechnology Cat. no. sc-203918 Tocris Bioscience Cat. no. 1625 |
![]() |
VU1545 N-[1-(2-Fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-4-nitrobenzamide Santa Cruz Biotechnology Cat. no. sc-204388 Tocris Bioscience Cat. no. 3325 |
![]() |
VU29 4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide Axon Medchem Cat. no. 1425 |
![]() |
| M1 mAchR Allosteric Agonist | |
VU0357017 Ethyl 4-({2-[(2-methylphenyl)formamido]ethyl}amino)piperidine-1-carboxylate hydrochloride Sigma-Aldrich Cat. no. V4640 |
![]() |
| M1 mAchR Antagonist | |
VU0255035 N-(3-oxo-3-(4-(pyridine-4-yl)piperazin-1-yl)propyl) benzo[c][1,2,5]thiadiazole-4-sulfonamide hydrate Santa Cruz Biotechnology Cat. no. sc-258334 Sigma-Aldrich Cat. no. V3765
Tocris Bioscience Cat. no. 3727 |
![]() |
| M1 mAchR Positive Allosteric Modulators | |
BQCA 1-[(4-methoxyphenyl)methyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Biotrend Chemicals Cat. no. BN0815 Enzo Life Sciences Cat. no. BML-C121-0010 and BML-C121-0050 |
![]() |
| M4 mAchR Positive Allosteric Modulators | |
VU10010 3-amino-N-(4-chlorobenzyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide Tocris Bioscience Cat. no. 3141 |
![]() |
VU152100 3-amino-N-(4-methoxybenzyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide Axon Medchem Cat. no. Axon 1483 Tocris Bioscience Cat. no. 3383 |
![]() |
| M5 mAchR Positive Allosteric Modulators | |
VU0238429 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethoxy)-2,3-dihydro-1H-indole-2,3-dione Tocris Bioscience Cat. no. 3634 |
![]() |